EA200200665A1 - Новые соединения бензолсульфонамида, способ их получения и фармацевтические композиции, их содержащие - Google Patents

Новые соединения бензолсульфонамида, способ их получения и фармацевтические композиции, их содержащие

Info

Publication number
EA200200665A1
EA200200665A1 EA200200665A EA200200665A EA200200665A1 EA 200200665 A1 EA200200665 A1 EA 200200665A1 EA 200200665 A EA200200665 A EA 200200665A EA 200200665 A EA200200665 A EA 200200665A EA 200200665 A1 EA200200665 A1 EA 200200665A1
Authority
EA
Eurasian Patent Office
Prior art keywords
group
benzolsulfonamide
receiving
pharmaceutical compositions
compositions containing
Prior art date
Application number
EA200200665A
Other languages
English (en)
Other versions
EA005403B1 (ru
Inventor
Жильбер Лавиелль
Бернар Симитьер
Тони Вербёрен
Серж Симоне
Кристин Вессетт-Курше
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200200665A1 publication Critical patent/EA200200665A1/ru
Publication of EA005403B1 publication Critical patent/EA005403B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Соединение формулы (I)в которой Rпредставляет собой гидрокси, алкокси, арилокси или арилалкилоксигруппу,А представляет собой группу СН атом азота, в в этом случае Rимеет значение, указанное в описании, или R-A совместно представляют собой атом кислорода или группув которой Rи Rимеют значения, указанные в описании,Rпредставляет собой атом водорода или алкильную группу,Rи R, которые могут быть одинаковыми или различными, каждый представляет собой атом водорода, атом галогена, алкильную группу, алкоксигруппу, гидроксигруппу или тригалоалкильную группу,n представляет собой целое число от 2 до 6 включительно,m и р представляют собой целые числа от 0 до 6 включительно.Лекарственные препараты.
EA200200665A 2001-07-13 2002-07-12 Соединения бензолсульфонамида, способ их получения и фармацевтические композиции их содержащие EA005403B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0109338A FR2827287B1 (fr) 2001-07-13 2001-07-13 Nouveaux derives de benzene sulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
EA200200665A1 true EA200200665A1 (ru) 2003-02-27
EA005403B1 EA005403B1 (ru) 2005-02-24

Family

ID=8865461

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200665A EA005403B1 (ru) 2001-07-13 2002-07-12 Соединения бензолсульфонамида, способ их получения и фармацевтические композиции их содержащие

Country Status (18)

Country Link
US (1) US6589956B2 (ru)
EP (1) EP1275644A1 (ru)
JP (1) JP4138382B2 (ru)
KR (1) KR100498864B1 (ru)
CN (1) CN1168715C (ru)
AR (1) AR036340A1 (ru)
AU (1) AU2002300093B2 (ru)
BR (1) BR0202674A (ru)
CA (1) CA2394037C (ru)
EA (1) EA005403B1 (ru)
FR (1) FR2827287B1 (ru)
HK (1) HK1050681A1 (ru)
HU (1) HUP0202286A2 (ru)
MX (1) MXPA02006852A (ru)
NO (1) NO323868B1 (ru)
NZ (1) NZ520140A (ru)
PL (1) PL354948A1 (ru)
ZA (1) ZA200205598B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2415846C2 (ru) * 2005-08-26 2011-04-10 Шионоги энд Ко., Лтд Производные, имеющие активность агонистов ppar-рецепторов
US10093640B2 (en) 2012-09-21 2018-10-09 Vanderbilt University Substituted benzofuran, benzothiophene and indole MCL-1 inhibitors
US10005728B2 (en) 2013-08-28 2018-06-26 Vanderbilt University Substituted indole Mcl-1 inhibitors
CN106456602B (zh) 2014-03-27 2020-11-24 范德比尔特大学 取代的吲哚mcl-1抑制剂
US9949965B2 (en) 2014-10-17 2018-04-24 Vanderbilt University Tricyclic indole Mcl-1 inhibitors and uses thereof
CA3016182C (en) 2016-03-04 2024-02-27 Vanderbilt Universtiy Substituted indole mcl-1 inhibitors
MX2022007947A (es) * 2019-12-24 2022-07-27 Sumitomo Pharma Co Ltd Derivado de amida de acido alifatico.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468882A (en) * 1966-10-07 1969-09-23 Sterling Drug Inc Phenylhydrazone derivatives as intermediates for preparing indoles
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
KR940007458B1 (ko) * 1991-11-21 1994-08-18 주식회사 금성사 박막 트랜지스터 제조 방법
TW219358B (ru) * 1991-12-20 1994-01-21 Hokuriku Pharmaceutical
EP0675109A1 (en) * 1992-12-21 1995-10-04 Taisho Pharmaceutical Co. Ltd N-substituted indole derivative
GB9317764D0 (en) * 1993-08-26 1993-10-13 Pfizer Ltd Therapeutic compound
FR2712591B1 (fr) * 1993-11-19 1996-02-09 Pf Medicament Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique.
KR100436812B1 (ko) * 1995-01-06 2004-08-31 도레이 가부시끼가이샤 벤젠축합헤테로환유도체및그유도체를유효성분으로함유하는의약조성물
AU7319096A (en) * 1995-11-02 1997-05-22 Merck Sharp & Dohme Limited Bicyclic heteroaryl-alkylene-(homo)piperazinones and thione analogues thereof, their preparation and their use as selective agonists of 5-ht1-like receptors
GB9523250D0 (en) * 1995-11-14 1996-01-17 Merck Sharp & Dohme Therapeutic agents
GB9523243D0 (en) * 1995-11-14 1996-01-17 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
ZA200205598B (en) 2003-03-27
HK1050681A1 (en) 2003-07-04
US6589956B2 (en) 2003-07-08
NO20023389L (no) 2003-01-14
JP2003064055A (ja) 2003-03-05
HU0202286D0 (ru) 2002-09-28
US20030109533A1 (en) 2003-06-12
EP1275644A1 (fr) 2003-01-15
AR036340A1 (es) 2004-09-01
JP4138382B2 (ja) 2008-08-27
PL354948A1 (en) 2003-01-27
FR2827287B1 (fr) 2003-10-31
KR20030007173A (ko) 2003-01-23
AU2002300093B2 (en) 2007-07-12
EA005403B1 (ru) 2005-02-24
CA2394037A1 (fr) 2003-01-13
CA2394037C (fr) 2008-04-29
NO323868B1 (no) 2007-07-16
MXPA02006852A (es) 2005-07-25
NO20023389D0 (no) 2002-07-12
HUP0202286A2 (hu) 2003-08-28
FR2827287A1 (fr) 2003-01-17
CN1397550A (zh) 2003-02-19
KR100498864B1 (ko) 2005-07-04
CN1168715C (zh) 2004-09-29
NZ520140A (en) 2003-09-26
BR0202674A (pt) 2003-05-06

Similar Documents

Publication Publication Date Title
EA200000327A2 (ru) Новые соединения аминотриазола, способ их получения и содержащие их фармацевтические композиции
CY1106858T1 (el) Νεα παραγωγα κυκλικου αμιδιου
HUP0001192A2 (hu) Topiramát és származékainak alkalmazása elhízás kezelésére használható gyógyszerkészítmények előállítására
MXPA05010638A (es) Aditivo para cemento.
DE60213609D1 (de) THIENOi2,3-döPYRIMIDINEDIONES ALS INHIBITOREN VON T-ZELLEN-PROLIFERATION
ES2188280T3 (es) Acetales heteroaril-ciclicos.
EA199800768A1 (ru) Новые производные эритромицина, способ их получения и их применение в качестве медикаментов
NO990583L (no) Cykliske eterforbindelser som natriumkanalmodulatorer
HUP0402235A2 (hu) 4,4-Difluor-1,2,3,4-tetrahidro-5H-1-benzazepin-származékok és ezek sói és ezeket tartalmazó gyógyszerkészítmények
ATE497948T1 (de) Bicyclische verbindungen
EA200100090A3 (ru) Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
EA200200665A1 (ru) Новые соединения бензолсульфонамида, способ их получения и фармацевтические композиции, их содержащие
HUP0201357A2 (hu) Aszimmetrikus rézkomplex, előállítása, és eljárás ciklopropánkarbonsav-észter-származékok előállítására felhasználásával
ATE502005T1 (de) Amphotere lipidverbindung und deren verwendung
DE69227695D1 (de) Substituierte chinoline für die behandlung von leismaniosen
HUP0004588A2 (hu) Szubsztituált 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-ol-származékok, eljárás előállításukra és alkalmazásuk gyógyszerként, valamint a vegyületeket tartalmazó gyógyszerkészítmények
EA200100059A3 (ru) Новые бензолсульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
ATE314352T1 (de) Anilide als acat-hemmer
EA200200611A1 (ru) Новые тетрагидропиридины, способ их получения и содержащие их фармацевтические композиции
DK0754185T3 (da) Fremgangmåde til fremstilling af 7-trialkylsilyl-baccatin III
EA200101230A1 (ru) Новые ингибиторы металлопротеаз, метод их получения и содержащие их фармацевтические композиции
EA200300458A1 (ru) Новые соединения аминотриазолона, способ их получения и фармацевтические композиции, содержащие их
HUP0301553A2 (hu) Gyógyászati készítmények és alkalmazásuk neurológiai rendellenességek kezelésére
EA200200807A1 (ru) Аминокислотные соединения и их применение в качестве ингибиторов nep, ace и ece
ATE380173T1 (de) Verfahren zur herstellung von (2s,3r,4s)-4- hydroxyisoleucin und analoga

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU